Prokarium to present at the Tumour Microenvironment Conference in Berlin, November 1-2, 2022

Alexandra Sevko, Prokarium’s Director of Translational Research will be presenting at the Tumour Microenvironment Conference
Title: Salmonella Typhi ZH9 as a novel microbial immunotherapy for bladder cancer
When/Where: November 1st, 2.30pm CET; Emerging therapeutics opportunity in IO session

Related News

Prokarium appoints Ibs Mahmood as Chief Executive Officer

London, UK – November 11, 2025 – Prokarium, a clinical-stage biopharmaceutical company pioneering the field of microbial immunotherapy, today announced the...

Prokarium expands IP portfolio with two new U.S. patents strengthening its position in bladder cancer

LONDON, United Kingdom, November 1, 2024 – Prokarium, a biopharmaceutical company developing innovative cancer treatments, today announced the...

Prokarium expands IP portfolio with two new U.S. patents strengthening its position in bladder cancer

LONDON, United Kingdom, November 1, 2024 – Prokarium, a biopharmaceutical company developing innovative cancer treatments, today announced the...

Prokarium Secures UKRI Grant to Fund Development of Living Cures Platform

LONDON, UK, March 14, 2024 – Prokarium announces they have been awarded a UK Research and Innovation (UKRI) Engineering Biology...

Prokarium Secures UKRI Grant to Fund Development of Living Cures Platform

LONDON, UK, March 14, 2024 – Prokarium announces they have been awarded a UK Research and Innovation (UKRI) Engineering Biology...